Carrageenan Nasal Spray in early treatment of common cold

• Research type

  Research Study

• Full title

  Efficacy and safety of Iota-Carrageenan nasal spray 1.2 g/l (0.12%) (Bisolviral®) versus placebo nasal spray in the early treatment of common cold.

• IRAS ID

  135347

• Contact name

  Moutaz S M Jawad

• Contact email

  jawadms@cardiff.ac.uk

• Sponsor organisation

  Boehringer Ingelheim

• REC name

  Wales REC 3

• REC reference

  13/WA/0222

• Date of REC Opinion

  24 Jul 2013

• REC opinion

  Further Information Favourable Opinion